 |
 |
| |
Click on audio icon to view synchronised audo and slide presentation.
Session I
 |
Chaired by Dr Alan Palmer Vernalis, UK |
|
|
|
|
 |
| |
Mitochondria, excitotoxicity and neurodegeneration
 |
Prof Tim Greenamyre Emory University, USA |
 |
 |
|
|
 |
| |
Mitochondria: a pore way to die
 |
Prof Andrew Halestrap University of Bristol, UK |
 |
 |
 |
|
 |
| |
Mitochondrial function and dysfunction in excitotoxic neuronal injury
 |
Prof Ian Reynolds University of Pittsburgh, USA |
 |
 |
 |
|
 |
| |
Session II
 |
Chaired by Dr David Cavalla Arachnova, UK |
|
|
|
|
 |
| |
The Apopstat: setting the death threshold for drug and toxin-induced apoptosis
 |
Dr John Hickman Servier, France |
 |
 |
 |
|
 |
| |
Regulation of cytochrome c-initiated caspase activation in apoptosis
 |
Prof Seamus Martin Trinity College, Dublin, Ireland |
 |
 |
|
|
 |
| |
Mitochondria as Potential Drug Targets
 |
Dr Anne Murphy Mitokor Corp., USA |
 |
 |
|
|
 |
| |
Session III
 |
Chaired by Dr Pam Greengrass Pfizer, UK |
|
|
|
|
 |
| |
Caspase inhibitors as neuroprotective agents
 |
Dr Michael F. James SmithKline Beecham, UK |
 |
 |
 |
|
 |
| |
Bax, mitochondria and apoptosis
 |
Dr Bruno Antonsson Serono-Ares, Geneva, Switzerland |
 |
 |
 |
|
 |
 |
 |
|
Welcome | Webcast | Faculty | About SMR | Technical Instructions
|
 |
© 2000 Prous Science. All rights reserved Send comments and questions to service@prous.com Legal Notice
|
 |